Literature DB >> 23626009

Smoking-related interstitial fibrosis (SRIF): pathologic findings and distinction from other chronic fibrosing lung diseases.

Anna-Luise A Katzenstein.   

Abstract

Smoking-related interstitial fibrosis (SRIF) is a common, histologically striking finding in smokers that must be distinguished from the idiopathic interstitial pneumonias and other chronic interstitial fibrosing lesions. It is characterised by marked thickening of alveolar septa by fibrosis composed of thick collagen bundles that have a distinctive hyalinised quality and often are admixed with variable numbers of hyperplastic smooth muscle fibres. There is minimal accompanying inflammation. This fibrosis is usually most prominent in subpleural and centrilobular parenchyma, but can be present elsewhere as well. It is accompanied by emphysema and respiratory bronchiolitis. Most patients are asymptomatic or only mildly symptomatic, and the clinical course is stable in most. This paper reviews the pathologic features of SRIF in detail, its differentiation from more ominous interstitial fibrosing processes, and the clinical implications of its diagnosis.

Entities:  

Keywords:  Lung; Pulmonary Pathology; Smoking; fibrosis

Mesh:

Year:  2013        PMID: 23626009     DOI: 10.1136/jclinpath-2012-201338

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

Review 1.  Combined pulmonary fibrosis and emphysema (CPFE): what radiologist should know.

Authors:  Federica Ciccarese; Domenico Attinà; Maurizio Zompatori
Journal:  Radiol Med       Date:  2016-02-19       Impact factor: 3.469

2.  Histopathology of Interstitial Lung Abnormalities in the Context of Lung Nodule Resections.

Authors:  Ezra R Miller; Rachel K Putman; Marina Vivero; Yin Hung; Tetsuro Araki; Mizuki Nishino; George R Washko; Ivan O Rosas; Hiroto Hatabu; Lynette M Sholl; Gary M Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2018-04-01       Impact factor: 21.405

3.  A 54-Year-Old Man Presenting With Progressive Dyspnea and Interstitial Lung Abnormalities.

Authors:  Lisa Huang; Sunkaru Touray; Ali Akalin; Sumera Ahmad
Journal:  Chest       Date:  2019-03       Impact factor: 9.410

4.  Pulmonary adenocarcinoma mutation profile in smokers with smoking-related interstitial fibrosis.

Authors:  Andrea Primiani; Dora Dias-Santagata; A John Iafrate; Richard L Kradin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-05-24

5.  Airway-centered interstitial fibrosis: etiology, clinical findings and prognosis.

Authors:  Lilian Tiemi Kuranishi; Kevin O Leslie; Rimarcs Gomes Ferreira; Ester Aparecida Ney Coletta; Karin Mueller Storrer; Maria Raquel Soares; Carlos Alberto de Castro Pereira
Journal:  Respir Res       Date:  2015-05-09

6.  Pulmonary dust foci as rat pneumoconiosis lesion induced by titanium dioxide nanoparticles in 13-week inhalation study.

Authors:  Yuko Goto; Tomoki Takeda; Shotaro Yamano; Shigeyuki Hirai; Yusuke Furukawa; Yoshinori Kikuchi; Tatsuya Kasai; Kyohei Misumi; Masaaki Suzuki; Kenji Takanobu; Hideki Senoh; Misae Saito; Hitomi Kondo; Yumi Umeda
Journal:  Part Fibre Toxicol       Date:  2022-09-14       Impact factor: 9.112

Review 7.  [Smoking-related interstitial lung diseases].

Authors:  Sebastian Röhrich; Benedikt H Heidinger; Florian Prayer; Daria Kifjak; Lucian Beer; Christian Wassipaul; Martin Watzenböck; Ruxandra-Iulia Milos; Helmut Prosch
Journal:  Radiologie (Heidelb)       Date:  2022-06-23

8.  Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.

Authors:  Brian D Hobbs; Rachel K Putman; Tetsuro Araki; Mizuki Nishino; Gunnar Gudmundsson; Vilmundur Gudnason; Gudny Eiriksdottir; Nuno Rodrigues Zilhao Nogueira; Josée Dupuis; Hanfei Xu; George T O'Connor; Ani Manichaikul; Jennifer Nguyen; Anna J Podolanczuk; Purnema Madahar; Jerome I Rotter; David J Lederer; R Graham Barr; Stephen S Rich; Elizabeth J Ampleford; Victor E Ortega; Stephen P Peters; Wanda K O'Neal; John D Newell; Eugene R Bleecker; Deborah A Meyers; Richard J Allen; Justin M Oldham; Shwu-Fan Ma; Imre Noth; R Gisli Jenkins; Toby M Maher; Richard B Hubbard; Louise V Wain; Tasha E Fingerlin; David A Schwartz; George R Washko; Ivan O Rosas; Edwin K Silverman; Hiroto Hatabu; Michael H Cho; Gary M Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2019-12-01       Impact factor: 21.405

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.